医学
入射(几何)
优势比
急性肾损伤
肌酐
风险因素
肾脏疾病
置信区间
肾脏替代疗法
内科学
队列研究
临床终点
回顾性队列研究
临床试验
光学
物理
作者
Stefan Herget‐Rosenthal,Kolja Stille,Klaus Albrecht,Hajo Findeisen,Martin Scharpenberg,Andreas Kribben
摘要
Abstract Background and hypothesis Although old age is a risk factor for acute kidney injury (AKI), data on AKI in individuals ≥80 years is limited. We aimed to provide data on AKI incidence, severity, and outcomes, to identify risk factors of AKI and 30-day mortality in those ≥80 years. Methods Cohort study of 2132 patients admitted to hospital. AKI was defined and classified by extended KDIGO criteria to detect community-acquired AKI, frailty as a clinical frailty score ≥5. Primary endpoints were AKI and its stages, secondary endpoints 30-day mortality and major adverse kidney events (MAKE30), a composite of mortality, new renal replacement therapy, or serum creatinine values ≥200% of baseline, all at 30 days. Results Median age was 86 years. AKI was frequent (35.3%) and predominately community-acquired (80.2%). The incidence rate of AKI rose with increasing age, reaching the maximum in patients 95 years old. 48.9% of AKI patients developed stage 1, while 27.0% and 24.1% reached stages 2 and 3, respectively. Frailty was identified as an independent AKI risk factor (adjusted odds ratio (aOR) 2.42 (95% confidence intervals (CI) 1.93–3.03). 30-day mortality rate was significantly higher in AKI compared to non-AKI patients (25.4 vs. 7.6%), 44.4% of AKI patients developed MAKE30. Among others, AKI and frailty were risk factors for 30-day mortality (aOR 3.02 (95% CI 2.25-4.07) and 1.53 (95% CI 1.16-2.02)), with frailty exceeding AKI in patients ≥90 years. Conclusions AKI occurs frequently, increases with age, is severe and predominately community-acquired in individuals ≥80 years admitted to hospital. Frailty is a risk factor for AKI besides established factors. Very old patients with AKI more frequently died or developed a high rate of the composite endpoint MAKE30. AKI and frailty are risk factors for 30-day mortality. The effect of frailty on mortality exceeded that of AKI in nonagenarians.
科研通智能强力驱动
Strongly Powered by AbleSci AI